Margins on orthopaedic implants as high as 300% of landed price

After capping the prices of cardiac stents and proving that huge margins at various levels of the supply chains is why the prices of stents were sky high, the National Pharmaceutical Pricing Authority (NPPA) has started monitoring the prices of other medical devices as well.

A recent report is on the margins in the supply chain for various orthopaedic implants. NPPA says the average margin on a full set of orthopaedic implants seems to be 313 per cent. The total trade margin is essentially the Maximum Retail Price (MRP) minus the import price. In this, distributor and hospital get a